News headlines about Simulations Plus (NASDAQ:SLP) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 46.8698564008995 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the headlines that may have impacted Accern’s scoring:
- Simulations Plus : to Present at LD Micro 10th Annual Main Event on December 6 (4-traders.com)
- Simulations Plus, Inc. :SLP-US: Earnings Analysis: 2017 By the Numbers : November 17, 2017 (finance.yahoo.com)
- Contrasting Greenway Health (GWAY) and Simulations Plus (SLP) (americanbankingnews.com)
- Reviewing Cotiviti Holdings (COTV) and Simulations Plus (SLP) (americanbankingnews.com)
- Simulations Plus posts 4Q profit (finance.yahoo.com)
Shares of Simulations Plus (NASDAQ SLP) traded down $0.20 during mid-day trading on Friday, hitting $15.80. 16,727 shares of the stock traded hands, compared to its average volume of 44,074. Simulations Plus has a twelve month low of $8.81 and a twelve month high of $17.45. The company has a market capitalization of $273.10, a PE ratio of 46.47 and a beta of -0.73.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Tuesday, November 14th. The technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. Simulations Plus had a net margin of 23.94% and a return on equity of 23.95%. The business had revenue of $6.30 million for the quarter, compared to analysts’ expectations of $5.01 million. analysts forecast that Simulations Plus will post 0.4 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 20th. Shareholders of record on Monday, November 13th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $0.24 dividend on an annualized basis and a yield of 1.52%. This is a boost from Simulations Plus’s previous quarterly dividend of $0.05. Simulations Plus’s dividend payout ratio (DPR) is currently 72.73%.
Several analysts have recently weighed in on the company. BidaskClub downgraded Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Zacks Investment Research cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th.
WARNING: This piece of content was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/11/19/simulations-plus-slp-getting-somewhat-positive-press-coverage-study-finds.html.
In other Simulations Plus news, major shareholder Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction dated Wednesday, September 27th. The shares were sold at an average price of $15.45, for a total value of $285,825.00. Following the transaction, the insider now owns 5,647,916 shares of the company’s stock, valued at $87,260,302.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 36.93% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.